Results to be Presented at International Orthopedics Foundation Annual Meeting Solana Beach, California, February 10, 2020 – Puregraft announced today results from the MICROPREP Clinical Trial: Intra-articular Injection of Fat and Platelet Rich Plasma as a Treatment for Knee Osteoarthritis. This phase IIa study was conducted by Dr Marie Laure Louis, orthopedic surgeon in Marseille, France (Clinique Juge, Almaviva group). The MICROPREP results will be presented by Dr. Jeremy Magalon (Assistance Publique – Hopitaux de Marseille) at the upcoming International Orthopedics Foundation Annual Meeting in Denver, Colorado. The MICROPREP study was a 30 patient, prospective, randomized, double-blind, single-center clinical trial [...]
SOLANA BEACH, CALIFORNIA (PRWEB) JULY 24, 2017 Puregraft, the global leader in the development and commercialization of autologous fat (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ‘398 patent) and South Korean Patent Number 10-1738324 (the ‘324 patent) for its adipose filtration technology. The ‘398 and ‘324 patents cover methods and systems for optimizing fat grafts for current and future generations of the Puregraft technology and offers protection against potential infringing parties. “The United States and South Korea are two of the largest fat transfer markets in the world. The issuance of the ‘398 and ‘324 [...]
San Diego, California, March 8, 2016 – Kerastem Technologies, a partner of Puregraft, is currently conducting an FDA study investigating hair loss in women and men. To learn more, visit https://kerastem.com/clinical-trial. About Puregraft Puregraft is a private company owned by Bimini Technologies. The Bimini portfolio of products also includes Kerastem Technologies LLC (www.kerastem.com) a leading hair growth company currently engaged in a Phase II clinical trial in the United States. The Kerastem Hair Therapy is CE Mark approved outside the United States.
SAN DIEGO, September 17 — Puregraft, the global leader in the development and commercialization of autologous fat (adipose) grafting systems has received U.S. Patent Number 9,133,431 (the ‘431 patent) for its adipose filtration technology. The ‘431 patent covers methods and systems for optimizing fat grafts for current and future generations of the Puregraft technology. “The issuance of our foundational Puregraft patent by the United States Patent and Trademark Office solidifies the protectability of our novel Puregraft technology,” said Bradford A. Conlan, CEO of Puregraft LLC. “We also expect the Puregraft patent portfolio to strengthen outside the United States in the [...]
Puregraft® Filtration for Autologous Fat Transfer Demonstrates Significantly Higher Long-Term Retention Compared to Centrifuged Controls
San Diego, California, July 21, 2014 – Puregraft LLC, a leader in the development and commercialization of autologous fat (adipose) grafting systems, is pleased to announce that a peer-reviewed paper evaluating the use of the Puregraft adipose filtration technology has been published in the July 2014 issue of Aesthetic Surgery Journal1. In this study, the investigators compared the rates of graft retention (an important measure of fat grafting success) in 26 patients, or 52 hemifaces, using the Puregraft technology versus a historical study of centrifuge processed fat grafts. The mean follow-up period was 17 months and the mean amount of [...]
Forbes Living features Puregraft’s improved fat grafting technology that’s used to safely and naturally re-contour the body to achieve a voluminous look. The producers of Forbes Living are excited to announce that Puregraft will be featured in an upcoming segment as part of their “World of Beauty” series. The show is hosted by Forbes Riley, an award-winning TV host in the D2C industry, author, entrepreneur, mother and one of the nation’s leading health and wellness experts. Facelifts, implants, and synthetic fillers are commonly used to combat aging, but there’s a new procedure that’s growing in popularity. Fat grafting, also referred to as [...]